Dr. Geeta Nayyar, also known as "Dr. G," is a highly respected rheumatologist and expert in health IT. She has played a significant role in advocating for public health and wellbeing in the tech industry. Through her talks, she effectively communicates the intersection of clinical medicine, business, and digital health, inspiring audiences to prioritize wellness in both their personal and professional lives. Dr. G's expertise lies in bridging the gap between clinical medicine, business, and digital health. She has served as the Chief Medical Officer at Salesforce and currently serves on the Board of the American Telemedicine Association and the University of Miami Miller School of Medicine Alumni Association. Her deep commitment to medical innovation positions her as a thought leader in the healthcare industry, earning her media appearances on CNN and PBS, as well as features on platforms like CNBC and Yahoo Finance. In her upcoming book, "Dead Wrong," set to release in the Fall of 2023, Dr. G dives into the root cause of medicine's "information illness" through a collection of rich stories and insights derived from the boardroom. She makes a compelling case for healthcare leaders to take responsibility for addressing the industry's challenges and promoting trust and health literacy on a broader scale. Dr. G's expertise is showcased in various featured videos and speaking engagements, where she discusses topics such as building trust in vulnerable communities, technology in healthcare, and the future of medical innovation. Additionally, she offers insights on women in leadership, drawing from her experiences in top-level positions at organizations like AT&T and Salesforce. Overall, Dr. Geeta Nayyar is a highly regarded rheumatologist and influential figure in the healthcare industry. Her work, knowledge, and commitment to promoting wellness and addressing healthcare challenges have earned her a prominent position as a leading voice in the field.
What is the future of medical innovation and how will we unlock the promise of new technologies? Which Scientific advances are most likely to immensely transform health outcomes and the deliverability of medicine?
Women in the C-Suite face the challenge of increasingly complex stakeholder relationships while disruptions to their business are becoming more pronounced. The new female leadership profile provides women with distinct advantages for building consensus towards accomplishing their goals, specifically from male stakeholders.
